ArticleNature chemical engineering2026
Hybrid bioprinting of hierarchical vascular networks at capillary-scale resolution.
Article in Nature chemical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Replicating the intricate hierarchical architecture of natural vascular networks, especially at capillary-scale resolution, remains a pivotal challenge in organ fabrication. Here we present a machine learning-enhanced hybrid bioprinting strategy that combines high-resolution aerosol jet printing of sacrificial materials and high-throughput extrusion printing of tissue matrices. This integrated approach enables sub-10 μm of resolution, achieving capillary-like channels and allowing on-demand modulation of vessel diameters in real time. Constrained Bayesian optimization rapidly identify optimal printing parameters, ensuring reliable, high-fidelity attainment of target channel sizes without exhaustive trial-and-error. This streamlined workflow supports the fabrication from 1D conduits to 3D multibranch hierarchical networks with tunable geometries. Endothelial cells seeded into these channels form continuous, functional monolayers, significantly reducing permeability while maintaining high cell viability and proliferation. By transcending the resolution limits of conventional sacrificial printing, this bioprinting method establishes a new route for producing biomimetic vasculature. Its unique combination of rapid optimization, real-time tunability, and microcapillary-scale precision holds exceptional promise for tissue engineering, regenerative medicine, and drug discovery.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.